Literature DB >> 19466521

Metabolic syndrome and anthropometric factors in Japanese patients with chronic kidney disease.

Yukako Sawara1, Takashi Takei, Keiko Uchida, Ken Tsuchiya, Kosaku Nitta.   

Abstract

A necessary condition for establishing new criteria for the metabolic syndrome (MetS) in Japan is waist circumference (WC), which varies among races. In the present study, we measured WC and visceral fat area (VFA) in patients with chronic kidney disease (CKD) and assessed the features of new MetS criteria in Japan. Two hundred and seventeen patients (M/F: 116/101, age: 59.1 +/- 13.0 years, body mass index: 24.1 +/- 3.9 kg/m(2)) who received abdominal computed tomography (CT) examinations were analyzed, and 93 subjects met the criteria for MetS. Average VFA was significantly larger in subjects with MetS (193.6 +/- 52.4 cm(2) versus 96.9 +/- 50.2 cm(2), P < 0.001). WC and VFA correlated significantly in both males (r = 0.71, P < 0.001) and females (r = 0.79, P < 0.001). Male and female CKD patients whose VFAs exceed 125 cm(2) have significantly more components of MetS, and the corresponding WC is 81.2 cm for males and 81.6 cm for females. From the ROC curve, 84 cm for males and 83 cm for females seemed to be suitable cut-off values in CKD patients. In conclusion, we propose suitable cut-off values of WC in Japanese CKD patients, with a high sensitivity for detecting the MetS, to be 84 cm for males and 83 cm for females. Further prospective analysis is required to validate these criteria and the clinical significance of MetS in Japanese CKD patients.

Entities:  

Mesh:

Year:  2009        PMID: 19466521     DOI: 10.1007/s00380-008-1107-0

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  22 in total

Review 1.  Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.

Authors:  T Funahashi; T Nakamura; I Shimomura; K Maeda; H Kuriyama; M Takahashi; Y Arita; S Kihara; Y Matsuzawa
Journal:  Intern Med       Date:  1999-02       Impact factor: 1.271

Review 2.  [Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome].

Authors: 
Journal:  Nihon Naika Gakkai Zasshi       Date:  2005-04-10

3.  A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population.

Authors:  Kazuo Hara; Yumi Matsushita; Momoko Horikoshi; Nobuo Yoshiike; Tetsuji Yokoyama; Heizo Tanaka; Takashi Kadowaki
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

Review 4.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

5.  Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men--the Tanno and Sobetsu Study.

Authors:  Hiroshi Takeuchi; Shigeyuki Saitoh; Satoru Takagi; Hirofumi Ohnishi; Junichi Ohhata; Takeshi Isobe; Kazuaki Shimamoto
Journal:  Hypertens Res       Date:  2005-03       Impact factor: 3.872

6.  Assessment of abdominal fat content by computed tomography.

Authors:  G A Borkan; S G Gerzof; A H Robbins; D E Hults; C K Silbert; J E Silbert
Journal:  Am J Clin Nutr       Date:  1982-07       Impact factor: 7.045

7.  Metabolic syndrome and chronic kidney disease in Okinawa, Japan.

Authors:  H Tanaka; Y Shiohira; Y Uezu; A Higa; K Iseki
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

8.  Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects.

Authors:  M Matsuda; F Kawasaki; K Yamada; Y Kanda; M Saito; M Eto; M Matsuki; K Kaku
Journal:  Diabet Med       Date:  2004-08       Impact factor: 4.359

9.  The metabolic syndrome and chronic kidney disease in U.S. adults.

Authors:  Jing Chen; Paul Muntner; L Lee Hamm; Daniel W Jones; Vecihi Batuman; Vivian Fonseca; Paul K Whelton; Jiang He
Journal:  Ann Intern Med       Date:  2004-02-03       Impact factor: 25.391

10.  Inpatients with coronary heart disease have a high prevalence of chronic kidney disease based on estimated glomerular filtration rate (eGFR) in China.

Authors:  Hao Liu; Jinming Yu; Fang Chen; Jue Li; Dayi Hu
Journal:  Heart Vessels       Date:  2007-07-20       Impact factor: 2.037

View more
  5 in total

1.  Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease.

Authors:  Jan Matejka; Ivo Varvarovsky; Petr Vojtisek; Ales Herman; Vladimir Rozsival; Veronika Borkova; Jiri Kvasnicka
Journal:  Heart Vessels       Date:  2010-09-29       Impact factor: 2.037

2.  Impact of chronic kidney disease on the severity of initially diagnosed coronary artery disease and the patient prognosis in the Japanese population.

Authors:  Hidenori Yagi; Makoto Kawai; Kimiaki Komukai; Takayuki Ogawa; Kosuke Minai; Tomohisa Nagoshi; Kazuo Ogawa; Hiroshi Sekiyama; Ikuo Taniguchi; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

3.  Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan.

Authors:  Takako Saito; Toshio Mochizuki; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta
Journal:  Heart Vessels       Date:  2012-04-21       Impact factor: 2.037

4.  Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes.

Authors:  Shun Manabe; Hiroshi Kataoka; Toshio Mochizuki; Kazuhiro Iwadoh; Yusuke Ushio; Keiko Kawachi; Kentaro Watanabe; Saki Watanabe; Taro Akihisa; Shiho Makabe; Masayo Sato; Naomi Iwasa; Rie Yoshida; Yukako Sawara; Norio Hanafusa; Ken Tsuchiya; Kosaku Nitta
Journal:  J Atheroscler Thromb       Date:  2020-08-06       Impact factor: 4.928

5.  Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease.

Authors:  Hiroshi Kataoka; Toshio Mochizuki; Kazuhiro Iwadoh; Yusuke Ushio; Keiko Kawachi; Saki Watanabe; Kentaro Watanabe; Taro Akihisa; Shiho Makabe; Shun Manabe; Masayo Sato; Naomi Iwasa; Rie Yoshida; Yukako Sawara; Norio Hanafusa; Ken Tsuchiya; Kosaku Nitta
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.